Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility
| Distributed by / for | Apothecary Pharma LLC |
| NDC | 85091-001-18 |
| Full product label | Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18. |
| Recalling firm | Apothecary Pharma LLC |
| Distribution | Nationwide within the United States |
| Quantity | 22 vials |
| Recall initiated | 2026-09-24 |
| Report date | 2026-10-14 |
| Recall completed | — |
| Recall number | D-0036-2027 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Cary NC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗